Cryptocurrency
Fortune
How GoodRx CEO Wendy Barnes is trying to halve the cost of GLP-1 obesity drugs
Why This Matters
Also: All the news and watercooler chat from Fortune.
August 19, 2025
08:31 AM
8 min read
Positive
Stay Ahead of the Market
Get weekly insights into market shifts, investment opportunities, and financial analysis delivered to your inbox.
No spam, unsubscribe anytime